IMC Chicago’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.78M Buy
11,538
+2,521
+28% +$1.21M ﹤0.01% 1979
2026
Q1
$4.43M Sell
9,017
-25,367
-74% -$13.8M ﹤0.01% 1878
2025
Q4
$19.9M Buy
34,384
+8,900
+35% +$5.03M 0.01% 853
2025
Q3
$12.4M Sell
25,484
-12,587
-33% -$5.86M ﹤0.01% 1037
2025
Q2
$15.4M Buy
+38,071
New +$15.9M 0.01% 810
2022
Q2
Sell
-19,094
Closed -$10.5M 1166
2022
Q1
$11.3M Buy
+19,094
New +$11M 0.01% 443
2021
Q2
Sell
-32,199
Closed -$15.2M 1189
2021
Q1
$14.7M Buy
32,199
+20,812
+183% +$9.93M 0.02% 364
2020
Q4
$5.3M Buy
+11,387
New +$5.34M 0.01% 536

Other funds holding TMO

IMC Chicago's TMO Position: Q2 2026 in Review

IMC Chicago increased its Thermo Fisher Scientific (TMO) stake by 28% in Q2 2026, buying an estimated $1.21M and bringing the position to 11,538 shares worth $5.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

IMC Chicago first reported a position in TMO in Q4 2020 and has held it in 8 quarters since. The position peaked at $19.9M in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • IMC Chicago held 11,538 shares of Thermo Fisher Scientific worth $5.78M as of Q2 2026.
  • IMC Chicago bought 2,521 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.21M.
  • Thermo Fisher Scientific made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1979 holding.
  • IMC Chicago first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 8 quarters since.
  • IMC Chicago's Thermo Fisher Scientific position peaked at $19.9M in Q4 2025.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.